Filing Details
- Accession Number:
- 0000919574-25-003572
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-12 20:27:44
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-12
- Accepted Time:
- 2025-06-12 20:27:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534260 | Casdin Partners Gp, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534261 | Casdin Capital, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534264 | Eli Casdin | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534265 | Casdin Partners Master Fund, L.p. | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No |
Transaction Summary
Sold: | 1,000,000 shares | Avg. Price: $23.80 | Total Value: $23,800,000.00 |
Number of Shares After Transactions: | 7,707,165 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2025-06-10 | 1,000,000 | $23.80 | 7,707,165 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Footnotes
- The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.